Circulation

NOVEMBER 11, 2024

Introduction:Smoking is a well-known risk factor for atherosclerotic cardiovascular disease and kidney failure among patients with chronic kidney disease (CKD). However, the association of former and current smoking status (vs.

Kidney Disease 40

Kidney Disease Heart Failure Blood Pressure Public Health 40

Circulation: Heart Failure

NOVEMBER 25, 2024

Circulation: Heart Failure, Volume 17, Issue 12 , Page e011629, December 1, 2024. Spironolactone, a steroidal mineralocorticoid receptor antagonist (MRA), has been used to treat patients with heart failure (HF) for more than half a century. The use of MRAs has been limited due to excessive concern about hyperkalemia.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Myocardial Infarction Kidney Disease 40

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Strokes Stroke 81

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among Results:Among 5002 (projected to 34.0

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

Cardiometabolic Health Congress

OCTOBER 10, 2024

Acorai : A heart failure monitoring platform using AI to track and predict patient health. Eko : AI-powered heart sound and EKG sensors paired with FDA-approved software for heart disease monitoring. RenalytixAI : Provides AI-enabled diagnostic solutions for early detection and management of kidney disease.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Implementation strategy: Utilize decision aids and patient education materials to facilitate informed discussions about treatment options, risks, and benefits. Open Communication Encouraging open, honest, and regular communication between patients and healthcare providers is essential. Key contributions: Advanced cardiac imaging (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Solomon, MD and Muthiah Vaduganathan, MD, MPH (USA) presented results showing that finerenone significantly reduced heart failure hospitalizations and cardiovascular death in patients with HFmrEF and HFpEF.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59